Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

Journal Article (Journal Article)

HLA disparity has a negative impact on the outcomes of hematopoietic cell transplantation (HCT). We studied the independent impact of amino acid substitution (AAS) at peptide-binding positions 9, 99, 116, and 156, and killer immunoglobulin-like receptor binding position 77 of HLA-A, B, or C, on the risks for grade 3-4 acute graft-versus-host disease (GVHD), chronic GVHD, treatment-related mortality (TRM), relapse, and overall survival. In multivariate analysis, a mismatch at HLA-C position 116 was associated with increased risk for severe acute GVHD (hazard ratio [HR] = 1.45, 95% confidence interval [CI] = 1.15-1.82, P = .0016). Mismatch at HLA-C position 99 was associated with increased transplant-related mortality (HR = 1.37, 95% CI = 1.1-1.69, P = .0038). Mismatch at HLA-B position 9 was associated with increased chronic GVHD (HR = 2.28, 95% CI = 1.36-3.82, P = .0018). No AAS were significantly associated with outcome at HLA-A. Specific AAS pair combinations with a frequency >30 were tested for association with HCT outcomes. Cysteine to tyrosine substitution at position 99 of HLA-C was associated with increased TRM (HR = 1.78, 95% = CI 1.27-2.51, P = .0009). These results demonstrate that donor-recipient mismatch for certain peptide-binding residues of the HLA class I molecule is associated with increased risk for acute and chronic GVHD and death.

Full Text

Duke Authors

Cited Authors

  • Pidala, J; Wang, T; Haagenson, M; Spellman, SR; Askar, M; Battiwalla, M; Baxter-Lowe, LA; Bitan, M; Fernandez-Viña, M; Gandhi, M; Jakubowski, AA; Maiers, M; Marino, SR; Marsh, SGE; Oudshoorn, M; Palmer, J; Prasad, VK; Reddy, V; Ringden, O; Saber, W; Santarone, S; Schultz, KR; Setterholm, M; Trachtenberg, E; Turner, EV; Woolfrey, AE; Lee, SJ; Anasetti, C

Published Date

  • November 21, 2013

Published In

Volume / Issue

  • 122 / 22

Start / End Page

  • 3651 - 3658

PubMed ID

  • 23982174

Pubmed Central ID

  • PMC3837514

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

Digital Object Identifier (DOI)

  • 10.1182/blood-2013-05-501510


  • eng

Conference Location

  • United States